Latest Breaking News On - மூன்று எதிர்மறை மார்பக புற்றுநோய் - Page 4 : comparemela.com

  Apollon Formularies Plc (AQSE: APOL) ( Apollon   or the  Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange is pleased to announce that its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing. ¹ This finding is in addition to the results recently announced on May 18, 2021² that Apollon formulations were successful in killing HER2+ breast cancer cells, and the announcement on June 28, 2021³ that Apollon formulations were successful in killing triple-negative breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ),a BC based international pharmaceutical company trading on the Canadian Securities Exchange. 

United kingdomUnited statesHerberta fritscheMegan rayPaul burkeTim blytheStephend barnhillStene jacobsApollon formularies plcAion therapeutic incApollon formularies jamaicaDirectors of the companyMd anderson cancer centerResearch developmentAi pharmaceuticals jamaicaLaboratory medicine